ADC measurements in the evaluation of lymph nodes in patients with non-Hodgkin lymphoma: feasibility study
- PMID: 20865296
- DOI: 10.1007/s10334-010-0226-7
ADC measurements in the evaluation of lymph nodes in patients with non-Hodgkin lymphoma: feasibility study
Abstract
Object: To determine whether apparent diffusion coefficient (ADC) measurements allow discrimination of normal lymph nodes from lymphomatous lymph nodes, and indolent lymphomas from aggressive lymphomas in patients with non-Hodgkin lymphoma (NHL).
Materials and methods: Eighteen healthy volunteers and thirty-two patients with newly diagnosed NHL (indolent: n = 16; aggressive: n = 16) underwent diffusion-weighted imaging. ADCs of normal lymph nodes were compared to those of lymphomatous lymph nodes, and ADCs of indolent lymphomas were compared to those of aggressive lymphomas. Receiver operating characteristic (ROC) analysis was performed when ADCs were significantly different between two of the aforementioned groups.
Results: ADCs (in 10(-3) mm(2)/s) of lymphomatous lymph nodes (0.70 ± 0.22) were significantly lower (P < 0.0001) than those of normal lymph nodes (1.00 ± 0.15). Area under the ROC curve was 0.865. Sensitivity and specificity were 78.1 and 100% when using an optimal cutoff ADC value of 0.80. On the other hand, ADCs of indolent lymphomas (0.67 ± 0.21) were not significantly different (P = 0.2997) from those of aggressive lymphomas (0.74 ± 0.23).
Conclusion: ADC measurements show promise as a highly specific tool for the discrimination of normal lymph nodes from lymphomatous lymph nodes, but appear to be of no utility in differentiating indolent from aggressive lymphomas.
Similar articles
-
Diagnostic value of diffusion-weighted magnetic resonance imaging: differentiation of benign and malignant lymph nodes in different regions of the body.Clin Imaging. 2015 Sep-Oct;39(5):856-62. doi: 10.1016/j.clinimag.2015.05.006. Epub 2015 May 22. Clin Imaging. 2015. PMID: 26091745
-
Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer.AJNR Am J Neuroradiol. 2003 Sep;24(8):1627-34. AJNR Am J Neuroradiol. 2003. PMID: 13679283 Free PMC article.
-
Value of diffusion-weighted MR imaging in the differentiation between benign and malignant cervical lymph nodes.Eur J Radiol. 2009 Dec;72(3):381-7. doi: 10.1016/j.ejrad.2008.09.034. Epub 2008 Nov 7. Eur J Radiol. 2009. PMID: 18995981
-
Differentiation of lymphomatous, metastatic, and non-malignant lymphadenopathy in the neck with quantitative diffusion-weighted imaging: systematic review and meta-analysis.Neuroradiology. 2019 Aug;61(8):897-910. doi: 10.1007/s00234-019-02236-7. Epub 2019 Jun 7. Neuroradiology. 2019. PMID: 31175398
-
Hodgkin and non-Hodgkin lymphoma of the head and neck: clinical, pathologic, and imaging evaluation.Neuroimaging Clin N Am. 2003 Aug;13(3):371-92. doi: 10.1016/s1052-5149(03)00039-x. Neuroimaging Clin N Am. 2003. PMID: 14631680 Review.
Cited by
-
Whole-body MRI for the detection of bone marrow involvement in lymphoma: prospective study in 116 patients and comparison with FDG-PET.Eur Radiol. 2013 Aug;23(8):2271-8. doi: 10.1007/s00330-013-2835-9. Epub 2013 Apr 17. Eur Radiol. 2013. PMID: 23591618
-
Correlations between functional imaging markers derived from PET/CT and diffusion-weighted MRI in diffuse large B-cell lymphoma and follicular lymphoma.PLoS One. 2014 Jan 15;9(1):e84999. doi: 10.1371/journal.pone.0084999. eCollection 2014. PLoS One. 2014. PMID: 24454777 Free PMC article.
-
Diffusion-Weighted Imaging (DWI) derived from PET/MRI for lymph node assessment in patients with Head and Neck Squamous Cell Carcinoma (HNSCC).Cancer Imaging. 2020 Aug 8;20(1):56. doi: 10.1186/s40644-020-00334-x. Cancer Imaging. 2020. PMID: 32771060 Free PMC article.
-
Whole-body diffusion-weighted MRI of normal lymph nodes: prospective apparent diffusion coefficient histogram and nodal distribution analysis in a healthy cohort.Cancer Imaging. 2021 Nov 27;21(1):64. doi: 10.1186/s40644-021-00432-4. Cancer Imaging. 2021. PMID: 34838136 Free PMC article.
-
Whole-body diffusion-weighted imaging with background body signal suppression and quantitative apparent diffusion coefficient in the detection, staging, and grading of non-Hodgkin lymphoma.Pol J Radiol. 2023 Mar 31;88:e177-e186. doi: 10.5114/pjr.2023.126393. eCollection 2023. Pol J Radiol. 2023. PMID: 37057202 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources